Investor Relations

Building Sustainable Future

NDB overview and recent achievements

The New Development Bank (NDB) is a multilateral development bank established by the Federative Republic of Brazil, the Russian Federation, the Republic of India, the People’s Republic of China and the Republic of South Africa (BRICS) in accordance with the Agreement on the New Development Bank signed on 15 July 2014.

The purpose of the NDB is to mobilize resources for infrastructure and sustainable development projects in BRICS and other emerging economies and developing countries, complementing the existing efforts of multilateral and regional financial institutions for global growth and development. For more detailed information about the projects financed by NDB please refer to the following link:

The Bank is rated AA+ by S&P Global Ratings and Fitch Ratings and AAA by China Chengxin International Credit Rating Co. Ltd (“CCXI”) and China Lianhe Credit Rating Co., Ltd. (“Lianhe Ratings”) Rating reports are available at:

The NDB has an initial authorized capital of USD 100 billion and initial subscribed capital of USD 50 billion of which USD 10 billion will be paid in seven installments. The initial subscribed capital is equally distributed amongst the founding members.

In July 2016, the NDB issued its debut bond in China. It was the first time that an international financial institution issued a green financial bond in the China Interbank Bond Market. The size of the issue is CNY 3 billion (USD 450mn). The bond has a 5-year tenor and nominal interest rate of 3.07%.

In February 2019, the NDB successfully placed CNY 3 billion bond in the China Interbank Bond Market under the debut Programme registered in January 2019. The bond was placed in two tranches with maturities of 3 years (CNY 2bn) and 5 years (CNY 1bn) with coupon rates of 3% and 3.32% respectively.

Highlights of the bonds are available at:

2019 Renminbi Bond (Series 1) (Bond Connect)
Download Prospectus (EN) Download Prospectus (CN)
Contact Us

For any investment-related queries, please reach out to